Valuation: InfuSystem Holdings, Inc.

Market Cap 184M 162M 150M 138M 259M 17.72B 263M 1.79B 697M 8.71B 691M 676M 30.13B P/E 2026 *
21.5x
P/E 2027 * 16.7x
Enterprise Value 184M 162M 150M 138M 259M 17.72B 263M 1.79B 697M 8.71B 691M 676M 30.13B EV / Sales 2026 *
1.27x
EV / Sales 2027 * 1.18x
Free-Float
92.85%
Yield 2026 *
-
Yield 2027 * -
1 day+2.59%
1 week+2.24%
Current month-5.49%
1 month-0.33%
3 months-11.80%
6 months+7.55%
Current year+1.67%
1 week 8.69
Extreme 8.6901
9.27
1 month 8.69
Extreme 8.6901
10.32
Current year 7.29
Extreme 7.29
11
1 year 5.43
Extreme 5.43
11.04
3 years 4.61
Extreme 4.61
11.44
5 years 4.61
Extreme 4.61
20.59
10 years 1.2
Extreme 1.2
23.26
Manager TitleAgeSince
Chief Executive Officer 49 2025-05-18
Director of Finance/CFO 55 2020-03-11
Chief Tech/Sci/R&D Officer 47 -
Director TitleAgeSince
Chairman 60 2018-12-18
Director/Board Member 64 2019-05-14
Director/Board Member 49 2021-03-17
Date Insider Type Main position Quantity % Market Cap.
5/18/26 Fiscal year

Chief Executive Officer

21,379 0.1058%
5/18/26 Fiscal year

Chief Technology Officer

12,888 0.0638%
5/18/26 Fiscal year

Chief Financial Officer

21,230 0.1050%
Change 5-day change 1-year change 3-year change Capi.($)
+2.59%+2.24%+54.31%-10.32% 184M
+2.29%+2.36%-17.97%-10.09% 180B
+1.46%+0.01%-9.87%-6.25% 107B
+1.58%+0.65%+6.69%+61.86% 60.29B
-1.13%-2.60%+26.37%+54.76% 50.19B
+2.22%-1.14%-14.85%-44.15% 43.08B
+2.98%-2.61% - - 32.77B
+1.50%-6.67%-17.52%-43.99% 27.61B
-7.67%-8.39%+17.59%-12.73% 23.1B
+1.63%-1.73%-5.80%-7.80% 20.86B
Average +0.74%-1.79%+4.33%-2.08% 54.41B
Weighted average by Cap. +1.28%-0.39%-6.61%+0.83%

Financials

2026 *2027 *
Net sales 145M 127M 118M 109M 204M 13.94B 207M 1.4B 549M 6.85B 543M 532M 23.7B 156M 137M 127M 117M 219M 14.99B 223M 1.51B 590M 7.37B 585M 572M 25.49B
Net income 8.85M 7.77M 7.22M 6.63M 12.46M 852M 12.65M 85.79M 33.52M 419M 33.21M 32.49M 1.45B 11.45M 10.05M 9.35M 8.58M 16.12M 1.1B 16.37M 111M 43.38M 542M 42.97M 42.05M 1.87B
Net Debt - -
Logo InfuSystem Holdings, Inc.
InfuSystem Holdings, Inc. is a national health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers. Its segments include Patient Services and Device Solutions. Its core service within its Patient Services segment is its Oncology Business. Patient Services supplies electronic ambulatory infusion pumps and associated disposable supply kits to private oncology clinics, infusion clinics and hospital outpatient oncology clinics to be utilized in the treatment of a variety of cancers, including colorectal cancer and other disease states. Its Device Solutions segment’s core service is to sell or rent new and pre-owned pole-mounted and ambulatory infusion pumps and other Durable Medical Equipment, sell treatment-related consumables, and provide biomedical recertification, maintenance and repair services for oncology practices and other healthcare site settings, including, home care and home infusion providers and others.
Employees
467
Date Price Change Volume
26-07-24 US$9.120 +2.59% 98,048
26-07-23 US$8.890 -0.11% 100,808
26-07-22 US$8.900 -2.73% 113,554
26-07-21 US$9.150 +2.35% 150,542
26-07-20 US$8.940 +0.22% 178,844
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
9.120USD
Average target price
14.88USD
Spread / Average Target
+63.10%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. INFU Stock